Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Faculty of Allied Health Sciences, Burapha University, Chon Buri, Thailand.
Mycopathologia. 2024 Oct 28;189(6):94. doi: 10.1007/s11046-024-00901-x.
Lodderomyces elongisporus, first isolated in 1952, has increasingly been recognized as a significant pathogen, with a notable rise in human infections since the 1970s. Initially misidentified as Candida parapsilosis due to morphological similarities, L. elongisporus has now been conclusively established as a distinct species, largely due to advancements in molecular biology, particularly DNA sequencing. This review traces the detection history of L. elongisporus, from the earliest documented cases to the most recent reports, underscoring its role as a causative agent in human infections. It also explores therapeutic strategies that have demonstrated efficacy, alongside instances of environmental contamination reported in international literature. A critical evaluation of diagnostic methodologies essential for precise identification is provided, including culture-based techniques such as colony morphology on Sabouraud Dextrose Agar (SDA) and chromogenic media, coupled with microscopic assessments using Lactophenol Cotton Blue (LPCB) and Gram staining. The ultrastructure of L. elongisporus, as observed under Scanning Electron Microscopy (SEM), is also discussed. Furthermore, non-culture-based diagnostics, such as sugar utilization tests (API 20C AUX and the innovative in-house arabinose-based "Loddy" test) and antifungal susceptibility profiling, are reviewed, with a particular focus on molecular tools like ITS-DNA sequencing and MALDI-TOF MS, which, despite their higher costs, offer unparalleled specificity. The accurate distinction and characterization of L. elongisporus are paramount, particularly in vulnerable and immunocompromised patients, where misdiagnosis can lead to severe consequences. This review advocates for intensified research efforts to develop more accessible diagnostic tools and deepen our understanding of this emerging pathogen, ultimately aiming to improve patient outcomes.
elongisporus 是在 1952 年首次分离出来的,它已逐渐被认为是一种重要的病原体,自 20 世纪 70 年代以来,人类感染的病例显著增加。由于形态相似,最初被错误地鉴定为近平滑假丝酵母,现在 elongisporus 已被明确确认为一个独特的物种,这主要归因于分子生物学的进步,特别是 DNA 测序。
本综述追溯了 elongisporus 的检测历史,从最早记录的病例到最近的报告,强调了它作为人类感染的病原体的作用。它还探讨了已证明有效的治疗策略,以及国际文献中报道的环境污染实例。
对用于精确鉴定的诊断方法进行了批判性评估,包括基于培养的技术,如沙氏琼脂(SDA)上的菌落形态和显色培养基,以及使用乳酚棉蓝(LPCB)和革兰氏染色的显微镜评估。还讨论了 elongisporus 的超微结构,如扫描电子显微镜(SEM)下观察到的结构。
此外,还回顾了非基于培养的诊断方法,如糖利用试验(API 20C AUX 和创新的基于阿拉伯糖的内部“Loddy”试验)和抗真菌药敏谱分析,特别关注分子工具,如 ITS-DNA 测序和 MALDI-TOF MS,尽管成本较高,但提供了无与伦比的特异性。
准确地区分和表征 elongisporus 至关重要,特别是在脆弱和免疫功能低下的患者中,误诊可能会导致严重后果。本综述主张加强研究努力,开发更易获得的诊断工具,并加深对这种新兴病原体的理解,最终旨在改善患者的预后。